Ceftum

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ceftum

What is Ceftum? Overview

Property Description
Active ingredient Cefuroxime (as axetil or sodium salt)
Form Tablets, Oral Suspension, Powder for Injection
Pharmacological class Antibiotic, Second-Generation Cephalosporin
General use Anti-infective agent (to fight bacterial illness)
Origin Synthetic

What Type of Medicine is Ceftum (Cefuroxime)?

Ceftum is a brand name for the synthetic medicinal substance Cefuroxime, which is classified as an antibiotic and specifically belongs to the second-generation cephalosporin group. This medication serves as a powerful anti-infective agent reserved for managing various bacterial illnesses. The drug’s classification within the larger beta-lactam family is well-established, positioning it as a key compound for systemic infection management.

The unique structure of Cefuroxime, particularly its stability against bacterial beta-lactamase enzymes, sets it apart from earlier cephalosporins, allowing it to maintain a broad-spectrum profile against a diverse range of susceptible pathogens. Its specific effectiveness against common causes of respiratory tract infections indicates the drug is designed to remain potent in the presence of defenses many bacteria produce.

Composition and Physical Forms of Cefuroxime

The core active ingredient is Cefuroxime, which is chemically modified into two primary forms to facilitate different routes of administration. For oral intake, the key component is Cefuroxime axetil, a prodrug formulated for optimal absorption in tablets or a liquid oral suspension. The substance is also manufactured as Cefuroxime sodium for parenteral delivery, which is supplied as a sterile powder for injection. This dual formulation ensures the drug is available for both initial clinical use and follow-up at-home treatment.

General Purpose and How Ceftum Works Against Bacteria

The general purpose of Ceftum is to resolve illness by targeting and eliminating susceptible bacteria that are causing an infection in the body. Cefuroxime achieves this function because it operates as a bactericidal agent, meaning its direct action is to actively kill the harmful microorganisms rather than merely slow their growth. Cefuroxime accomplishes this by disrupting a fundamental biological process: the final stage of bacterial cell wall synthesis, ultimately leading to the breakdown and death of the pathogen.

Regulatory References

  1. Cefuroxime: MedlinePlus Drug Information

What side effects are possible with Ceftum?

Possible Side Effects and Safety Information

This section outlines the officially documented adverse reactions and safety constraints for Ceftum (Cefuroxime Axetil) as classified in regulatory documents.


Frequency-Classified Adverse Reactions

Adverse reactions are classified by their reported frequency:

  • Common (may affect up to 1 in 10 people): Eosinophilia (changes in white blood cells), headache, dizziness, diarrhea, nausea, vomiting, and transient elevation in liver enzyme levels (AST, ALT, LDH).
  • Uncommon (may affect up to 1 in 100 people): Positive Coomb's test, skin rash, pruritus (itching), and urticaria (hives).
  • Rare or Not Known (post-marketing reports): Serious reactions including hemolytic anemia, thrombocytopenia, leukopenia, seizures, and severe cutaneous adverse reactions (SCARs).

Serious Adverse Reactions and Safety Constraints

  • Serious Hypersensitivity: Immediate cessation of use is required if signs of a serious allergic reaction, such as anaphylaxis, occur. Ceftum is contraindicated in individuals with a known severe hypersensitivity history to any cephalosporin or beta-lactam antibacterial agents (e.g., penicillins).
  • C. difficile-Associated Diarrhea (CDAD): This condition, which may range from mild to life-threatening colitis, has been reported and can occur up to two months after treatment is complete.
  • Neurotoxicity: Seizures and encephalopathy have been reported, particularly in cases of renal impairment where drug accumulation is likely. Dosage adjustment is required for patients with reduced kidney function to prevent drug accumulation.

Population-Specific Notes

  • Renal Impairment: Requires dose adjustment to mitigate the risk of adverse events, including neurotoxicity.
  • Pregnancy/Lactation: Use is generally reserved only when clearly needed. Cefuroxime is excreted in breast milk, and caution is advised.

Overdose and Emergency Response

If you suspect an overdose of Ceftum (cefuroxime), you must seek emergency medical attention immediately. Taking more than the prescribed dose can lead to an increase in the medicine's concentration in the body, which can be particularly concerning for individuals with pre-existing kidney problems, as this organ is responsible for clearing the drug.

Potential Signs of Overdose

Symptoms of a significant overdose may include indications of cerebral irritation, such as:

  • Seizures (convulsions)
  • Encephalopathy (brain disease or damage)

These symptoms represent a serious medical emergency.

When to Seek Emergency Help

Call emergency services or go to the nearest emergency room immediately if you or someone else has taken too much Ceftum. Supportive medical care is typically provided in a hospital setting, which may include measures to protect the airway and control seizures. In cases of severe overdose, hemodialysis or peritoneal dialysis may be used to help reduce the drug concentration in the bloodstream. Prompt treatment is crucial to mitigate potential risks associated with high drug levels.

Therapeutic Uses of Ceftum

Ceftum (Cefuroxime) is commonly used to help with bacterial infections and may assist with managing symptoms related to systemic imbalance, applied in clinical settings that involve acute or unstable symptom patterns. It is used in situations where pronounced symptoms are driven by susceptible bacterial pathogens.

Ceftum is considered relevant for conditions presenting with systemic or localized discomfort across several domains, including those affecting the respiratory system, the skin, soft tissues, and the urinary tract. The therapeutic benefit contributes to easing the overall symptom load, and supports general well-being during symptomatic phases.

This antibiotic is considered relevant for conditions such as acute sinusitis, tonsillitis/pharyngitis, otitis media, and uncomplicated UTIs. It also plays a role in managing early presentations of Lyme Disease and may be part of symptomatic management as surgical prophylaxis when infection risk is present.


Quick Fact: Support for symptoms related to Inflammatory and Irritative States

Ceftum helps with maintaining functional stability by easing discomfort associated with inflammatory states, whether that is local inflammation in the throat, ear, or sinuses, or generalized symptoms that create noticeable physiological strain.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Ceftum?

Ceftum (Cefuroxime) is an antibiotic whose official eligibility for use is strictly defined by government regulatory documents, primarily based on patient history, age, and pre-existing medical conditions.


Official Contraindications

Ceftum is absolutely contraindicated for individuals with a known history of hypersensitivity to Cefuroxime axetil or to any other beta-lactam antibacterial drugs, including penicillins and cephalosporins. These individuals must not use the medicine.


Age and Condition Restrictions

Population Group Eligibility Status
Infants under 3 months Use is not recommended as safety and efficacy have not been established.
Patients with PKU Must not use the oral suspension formulation because it contains phenylalanine.
Impaired Renal Function Use is conditional due to altered drug elimination, requiring specific medical management.
Pregnancy Use is restricted to only if clearly needed, based on limited human data.
Lactation Use is conditional, requiring a benefit/risk assessment due to excretion in breast milk.

Adults and pediatric patients 3 months of age and older are generally eligible, provided they meet the formulation requirements (e.g., ability to swallow tablets whole). These rules ensure compliance with the official eligibility framework defined by regulatory authorities.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define the interaction profile of Ceftum (Cefuroxime) primarily through effects on drug exposure and pharmacodynamic outcomes, strictly outlining substances that require restriction.


Pharmacokinetic and Systemic Exposure Interactions

Co-administration with Probenecid is formally not recommended because this substance inhibits the renal tubular secretion of Cefuroxime. This interaction significantly increases the systemic exposure to the antibiotic, elevating plasma concentrations and the drug's half-life.

The bioavailability of the oral form, Cefuroxime axetil, is officially reduced by concurrent use of drugs that reduce gastric acidity, such as H2-receptor antagonists or antacids. This combination should generally be avoided to prevent diminished absorption.


Pharmacodynamic and Product-Efficacy Interactions

Cefuroxime interacts with Oral Anticoagulants (e.g., Warfarin), a combination that may officially be associated with a prolonged prothrombin time and an increase in INR. This risk is specifically documented to be heightened in patients with existing renal or liver dysfunction.

Concomitant use with Potent Diuretics (e.g., Furosemide) or Aminoglycosides has a documented additive risk of nephrotoxicity. Additionally, Cefuroxime may reduce the efficacy of Combined Oral Contraceptives due to its documented effect on gut flora, which can lower estrogen reabsorption.

Drug/Laboratory Test Interactions

Cefuroxime is documented to cause false-positive results for glucose in the urine with copper reduction tests and false-negative results for blood/plasma glucose with ferricyanide tests, a formal constraint noted in regulatory labeling.

Mechanism of Action

Targeting the Core Mechanism of Bacterial Cell Wall Collapse

The active component, Cefuroxime, exerts its primary effect by acting as an irreversible inhibitor of bacterial enzymes known as Penicillin-Binding Proteins (PBPs). These transpeptidases are essential for catalyzing the final cross-linking step of the peptidoglycan polymer, which provides structural integrity to the bacterial cell wall. Cefuroxime covalently binds to the PBP active site, preventing this crucial polymerization. This specific molecular blockade initiates a cascade, leading to the uncontrolled activation of bacterial autolytic enzymes. The resulting structural instability and degradation cause the cell to rupture via high internal osmotic pressure, leading to a bactericidal action against susceptible organisms.

Mechanistic Limitation: Evasion by boldsymbolbeta-Lactamase Enzymes

This mechanism's functional capacity is constrained by bacterial resistance enzymes called boldsymbolbeta-lactamases. These enzymes chemically deactivate Cefuroxime by hydrolyzing the beta-lactam ring structure before the molecule can inhibit the PBPs. This mechanistic limitation prevents the cell-lysis cascade, allowing bacterial proliferation to continue.

Dosage and Administration Information

How to Use Ceftum (Cefuroxime): Official Administration Guidelines

The proper administration of Ceftum is governed by specific instructions concerning its route, form, and dosing schedule. This antibiotic is available for both oral and parenteral (injection) use.

Approved Routes and Standard Frequency

Route and Form Active Ingredient Standard Frequency
Oral (Tablets/Suspension) Cefuroxime axetil Twice daily (Every 12 hours)
Parenteral (IV/IM Injection) Cefuroxime sodium Three times daily (Every 8 hours)

Contextual Administration Instructions

  1. Oral Tablets can be taken with or without food for convenience. The tablets must be swallowed whole and should not be crushed, split, or chewed.
  2. Oral Suspension (liquid form) must be taken with food to ensure optimal absorption. The powder must be properly reconstituted and shaken well before each use.
  3. Parenteral Administration is used for more severe conditions and includes Intravenous (IV) or Intramuscular (IM) injection. IV administration is performed as a slow injection over 3 to 5 minutes or an infusion over 30 to 60 minutes.

Dosing and Duration

Typical oral doses range from 250 mg to 500 mg per dose for most infections. The duration of therapy is commonly 7 to 10 days, although treatment for conditions like early Lyme disease may be extended to 20 days. Dose adjustments are explicitly required for adult patients with renal impairment (kidney function impairment), where frequency is reduced if creatinine clearance is low.

Recent Clinical Evidence

Ceftum: Recent Clinical Evidence

Ceftum is a brand name for cefuroxime axetil, an antibiotic classified as a second-generation cephalosporin. Clinical studies and regulatory approvals have evaluated its use in treating a range of infections caused by susceptible bacteria.

Clinical Findings by Infection Type

Research has explored the role of oral cefuroxime axetil in various community-acquired bacterial infections. Key areas of investigation have included:

  • Respiratory Tract Infections: Clinical trials involving patients with upper and lower respiratory infections, such as acute bacterial sinusitis, tonsillitis/pharyngitis, and acute exacerbations of chronic bronchitis, have consistently reported satisfactory outcomes.
  • Acute Otitis Media: Studies in both adult and pediatric populations (typically over 3 months of age) have assessed its utility in treating ear infections caused by susceptible organisms like Streptococcus pneumoniae and Haemophilus influenzae.
  • Early Lyme Disease: Evidence supports the use of cefuroxime axetil in treating the early stage of Lyme disease, known as erythema migrans, following tick exposure.
  • Urinary Tract and Skin Infections: Cefuroxime axetil has also been included in studies for treating uncomplicated urinary tract infections (UTIs) and infections of the skin and soft tissues.

Comparative and Short-Course Studies

Comparative clinical research has been conducted to assess cefuroxime axetil against other established oral antibiotics, such as amoxicillin/clavulanate. These comparisons often focus on both clinical response rates and the profile of observed gastrointestinal side effects. For certain indications, such as acute bronchitis, some trials have investigated whether a shorter course of treatment (e.g., five days compared to ten days) could achieve comparable therapeutic results and bacterial eradication rates.

Overall, the body of evidence supports the use of cefuroxime axetil as a therapeutic option for infections within its established spectrum of activity, and its safety profile is monitored through ongoing post-marketing surveillance.

Frequently Asked Questions (FAQ)

Common questions about Ceftum (FAQ)


Q: What is the main difference between Ceftum and amoxicillin?

Ceftum (cefuroxime) is classified as a second-generation cephalosporin antibiotic, belonging to the same broad class of beta-lactam drugs as amoxicillin (a penicillin). Official documents state that a history of severe allergy to penicillins is considered a contraindication for Ceftum. The drug’s classification indicates its structure is designed to be stable against certain bacterial defense mechanisms.


Q: How quickly should I expect Ceftum to start working?

Official patient counseling information notes that it is common to feel better early in the course of therapy when taking Ceftum. The full course of medication, as prescribed, should be taken to ensure the infection is fully treated.


Q: Are there any common foods or drinks to avoid while taking Ceftum?

According to the official product information, there are no specific common foods or drinks that must be strictly avoided. The tablet form can be taken with or without food. However, the oral suspension (liquid form) must be taken with food to ensure optimal absorption of the medication into the body.


Q: Is Ceftum safe to take if I am allergic to penicillin?

Official regulatory documents state that Ceftum is contraindicated (meaning use is prohibited) in individuals who have a known history of severe hypersensitivity, such as anaphylaxis, to Ceftum or to other beta-lactam antibacterial drugs, including penicillins. This is due to the potential for cross-reaction between the drug classes.


Q: What happens if I miss a scheduled dose of Ceftum?

Official patient guidance for handling a missed dose may suggest taking it as soon as it is remembered. However, if it is almost time for the next scheduled dose, guidance may suggest skipping the missed dose to avoid doubling up the amount taken. The regular dosing schedule is then resumed.


Q: How long does Ceftum stay in your system after the last dose?

According to pharmacokinetic data, the elimination half-life of Ceftum is short, approximately 1.2 to 1.5 hours in adults with normal kidney function. This means half of the drug is eliminated in that time. The drug is largely removed from the body unchanged through the urine.


Q: Can taking Ceftum cause a yeast infection?

Official adverse reaction reports indicate that taking Ceftum may be associated with vaginitis (vaginal inflammation) and vaginal itch in some subjects. Vaginal candidiasis (yeast infection) has also been noted in post-marketing reports, as antibiotics can alter the body’s normal balance of organisms.


Q: Is Ceftum considered safe during pregnancy?

Official regulatory information states that the use of Ceftum during pregnancy is generally restricted and is reserved only if clearly needed. This is based on limited available human data regarding the drug-associated risk to the developing fetus.


Q: What is the purpose of the layer around the tablet (film-coating) of Ceftum?

The tablet is film-coated for administration purposes. Official patient counseling notes that the tablets must be swallowed whole and should not be crushed, split, or chewed. This coating helps manage the fact that the crushed tablet has been reported to have a strong, persistent, bitter taste.


Q: Is there any research on Ceftum's use for chronic conditions?

Official indications show that Ceftum is used to treat specific acute infections, but its use does include the treatment of acute bacterial exacerbations of chronic bronchitis. Additionally, the therapy for Early Lyme Disease is noted to be an extended course, lasting up to 20 days.


Q: Is Ceftum known to affect sleep patterns?

Altered sleep patterns are not listed as a common side effect of Ceftum. However, adverse reaction reports have included common effects like headache and dizziness, and less common effects like somnolence (sleepiness) in clinical trial subjects.


Q: Does the time of day I take Ceftum matter?

Official dosage instructions specify a consistent time interval between doses, typically every 12 hours (twice daily). Maintaining a consistent time interval between doses helps ensure that effective drug levels are maintained in the body, which is important for treatment.


Q: Are there specific symptoms that indicate I should stop taking Ceftum?

Official warnings state that the medication should be discontinued if signs of a serious hypersensitivity reaction, such as anaphylaxis (a severe allergic reaction), occur. Appropriate medical attention is required in such a situation.


Q: Is there a generic version of Ceftum available?

The active ingredient in Ceftum is cefuroxime axetil, which is the internationally recognized generic name for the oral form. The availability of generic products depends on local regulations and market conditions.


Q: Can I take Ceftum if I have diabetes?

Official warnings advise that Ceftum is documented to cause false-positive results for glucose in the urine when copper reduction tests are used. Official documentation notes that patients with diabetes should be aware of this laboratory interaction and the need to use glucose tests based on enzymatic glucose oxidase reactions to avoid inaccurate readings.


Q: Is it important to finish the whole course of Ceftum?

Official patient counseling emphasizes that the medication is intended to be taken for the full prescribed duration. Skipping doses or not completing the full course may increase the likelihood of the bacteria developing resistance to the antibiotic.


Q: What are the common misunderstandings about Ceftum online?

Official patient counseling materials address the fact that antibiotics are often misused, stating that Ceftum should only be used to treat bacterial infections. It will not treat viral infections such as the common cold or flu.


Q: Is it normal for a tongue to look different after taking Ceftum?

While a change in tongue appearance is not a common side effect, official adverse reaction reports, including post-marketing data, have included reports of a swollen tongue in a small percentage of subjects.

How should Ceftum be stored and disposed of?

How to Store and Dispose of Ceftum (Cefuroxime Axetil)

The storage requirements for Ceftum are dependent on the formulation, as defined by official labeling.


Required Storage Conditions

Formulation Temperature Requirement Stability Constraint
Tablets Controlled Room Temperature (20 C to 25 C) Must not be refrigerated
Oral Suspension (Reconstituted) Refrigerated (2 C to 8 C) Must not be frozen; discard after 10 days

All forms must be stored in a tightly closed container and protected from light and moisture. The medicine must be kept strictly out of the reach of children.

Disposal

Unused or expired product should be disposed of via a drug take-back program or in accordance with local regulations. The medicine should not be flushed down a toilet or sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ceftum found in:

A-Z Index: